Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2003
10/21/2003US6635477 Comprising a open reading frame; use in diagnosis, treatment and prevention
10/21/2003US6635460 Fructosyltransferases
10/21/2003US6635287 Obtaining an extract from producer cells derived from an organism which is xenogeneic to said target cells and which is capable of entering into a dormant state
10/21/2003US6635285 Fractionating crude extract with water soluble biologically active components; low and high molecular weight components are separated; anti -angiogenic, -tumor, -inflammatory and -collagenolytic
10/21/2003US6635260 Composition comprising carrier and at least one non-toxigenic strain of Clostridium difficile which does not produce toxins A and B, from selected groups defined by restriction endonuclease analysis of total genomic DNA on agarose gels
10/21/2003US6635258 Herpes simplex virus VP22 vaccines and methods of use
10/21/2003US6635248 Isolated polypeptide consisting of single chain of amino acids comprising one or more penetrating fragments from one or more penetrating antibodies, which penetrates into cell
10/21/2003US6635244 Adenovirus E1B-55K single amino acid mutants and methods of use
10/16/2003WO2003085728A1 Carrier, method of manufacturing a carrier and an electronic device
10/16/2003WO2003085123A2 Methods anc compositions for in vivo clearance of pathogens
10/16/2003WO2003085097A1 Method of preparing a probiotic preparation
10/16/2003WO2003085092A2 Cellular transplantation for heart regeneration
10/16/2003WO2003084571A1 Therapeutic composition for bone infectious disease
10/16/2003WO2003084468A2 Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof
10/16/2003WO2003084431A2 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering
10/16/2003WO2003084344A2 Method of improving absorption of vitamin e by a pet animal
10/16/2003WO2003084343A2 Method and dietary composition for improving fat digestibility
10/16/2003WO2003084342A2 Method and dietary composition for improving lipid digestibility
10/16/2003WO2003084302A2 Anti-aging agent
10/16/2003WO2003072707A3 Compositions comprising reproductive cell media and methods for using such compositions
10/16/2003WO2003068954A3 Microorganism for genetic therapeutic treatment of proliferative diseases
10/16/2003WO2003068809A3 An herpes simplex virus complex
10/16/2003WO2003062405A3 Method for inducing differentiation of embryonic stem cells
10/16/2003WO2003048344A3 Differentiation of human embryonic stem cells in avian embryos
10/16/2003WO2003047533A3 Composition for treating the surface of the skin
10/16/2003WO2003045335A3 Stem cell screening and transplantation therapy for hiv infection
10/16/2003WO2003042368A3 Methods of expressing lim mineralization protein in non-osseous cells
10/16/2003WO2003040316A3 Selective elimination of cd52+ cells and uses thereof
10/16/2003WO2003040298A3 Cell and tissue growth using substances that reversibly bind oxygen
10/16/2003WO2003038073A3 Method for enhancing keratinocyte stem cells
10/16/2003WO2003038062A3 Generation of use of tc1 and tc2 cells
10/16/2003WO2003031640A3 Preadipocyte cell strains and uses therefore
10/16/2003WO2003014317A3 Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof
10/16/2003WO2003004520A3 Mycobacterial antigens expressed during latency
10/16/2003WO2002070655A3 Mouse cytokine receptor
10/16/2003WO2002064065A3 Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation
10/16/2003WO2002057430A3 Pluripotent adult stem cells derived from regenerative tissue
10/16/2003WO2002056898A3 Immunomodulator for the management of human immunodeficiency virus (hiv) disease/infection
10/16/2003WO2002056865A3 Peat product composition, method for the production and use thereof
10/16/2003WO2002056804A3 Presbyopia treatment by lens alteration
10/16/2003WO2002044384A3 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
10/16/2003WO2002024307A3 Reducing the content of particular cell types in a biological sample
10/16/2003WO2002007739A9 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma
10/16/2003US20030196213 Extending the life span of sperm by including an phosphodiesterase enzyme inhibitors; side effect reduction
10/16/2003US20030195337 UL16 binding protein 4
10/16/2003US20030195261 Administering racemic or optically pure sibutramine metabolite, or a pharmaceutically acceptable salt, solvate, or clathrate for prophylaxis or therapy
10/16/2003US20030194806 Synthetic media for blood components
10/16/2003US20030194804 For enhancing T cell response to tumour cells
10/16/2003US20030194803 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/16/2003US20030194802 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/16/2003US20030194800 For immunization, generation of packaging cell lines, and production of immunogenic compositions
10/16/2003US20030194758 Methods for the identification of fungal glucose utilization inhibitors and antifungal agents
10/16/2003US20030194746 For diagnosis, prognosis, prophylaxis
10/16/2003US20030194694 Pure recombinant influenza virus comprising a mutant ion channel protein which lacks or has reduced activity relative to the wild-type
10/16/2003US20030194450 Method of producing a preparation containing active substances from cannabis
10/16/2003US20030194413 Methods and compositions employing red rice fermentation products
10/16/2003US20030194397 Introducing platelet-rich plasma into and around the site of the injury
10/16/2003US20030194395 Th1 cell adoptive immunotherapy
10/16/2003US20030194394 Adding a microbial culture of a fermentation medial containing an anticholesterol agent to animal feed
10/16/2003US20030194391 Vaccine
10/16/2003US20030192555 Direct arterial infiltration for production of vascular pathology
10/16/2003CA2480709A1 Method of improving absorption of vitamin e by a pet animal
10/16/2003CA2480446A1 Method and dietary composition for improving lipid digestibility
10/16/2003CA2476551A1 Methods and compositions for in vivo clearance of pathogens
10/15/2003EP1352960A1 Antiviral therapy on the basis of RNA interference
10/15/2003EP1352955A2 HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constitutuent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/15/2003EP1352566A1 Process for the manufacture of a preparation containing active principles from cannabis
10/15/2003EP1352072A2 Nucleic acid delivery formulations
10/15/2003EP1352056A2 Polypeptides
10/15/2003EP1352054A2 Aspergillus ochraceus 11 alpha hydrolase and oxidoreductase
10/15/2003EP1352053A2 Method for processing dendritic cells and for activating macrophages with ru 41740
10/15/2003EP1351978A2 Retrovirus isolated from humans
10/15/2003EP1351969A1 Method for generating immortal dendritic cell lines
10/15/2003EP1351967A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/15/2003EP1351708A1 Therapeutic agent comprising a b-subunit of a protein toxin
10/15/2003EP1351699A1 Methods for improved diagnosis and treatment of mycobacterial infections
10/15/2003EP1351697A2 Pharmaceutical for stimulating the regeneration of tissues
10/15/2003EP1351663A1 Cosmetic and/or pharmaceutical preparations
10/15/2003EP1351662A1 Cosmetic and/or pharmaceutical preparations
10/15/2003EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease
10/15/2003EP0925077B1 Method for obtaining a purified collagen-based matrix from submucosa tissue
10/15/2003EP0876140B1 Improved kontrast agent solutions for intravenous administration
10/15/2003CN2579417Y Combined gel box
10/15/2003CN1449448A 干细胞分化 Stem cell differentiation
10/15/2003CN1449439A Cell fraction containing cells capable of differentiating into nervous system cells
10/15/2003CN1448498A Health preserving wine and its making method
10/15/2003CN1448180A Prep. of capsule for promoting hepatocyte growth hormone
10/15/2003CN1448146A 珍珠混悬液 Pearl suspension
10/15/2003CN1448140A Sea urchin containing preparation and its preparing method
10/15/2003CN1124348C Multi-functional hematopoietic receptor agonists
10/15/2003CN1124160C Method for the microbial decontamination of blood platelets
10/15/2003CN1124156C Chinese-medicinal pills for treating rheumatism and preparing process thereof
10/15/2003CN1124154C Medicine for treating piles and its preparing process
10/15/2003CN1124153C Medicinal composition for restoring cardiac collaterals and its application
10/15/2003CN1124151C Medicine for treating tuberculosis
10/15/2003CN1124149C Chinese medicine capsule mainly for treating cerebral infraction
10/15/2003CN1124147C Composite trichogen
10/15/2003CN1124145C Chinese patent medicine for treating allergic dermatopathy
10/15/2003CN1124141C Xinnaofukang capsule-for treating angiocardiopathy and cerebrovascular disease and its preparing process
10/15/2003CN1124140C Chinese medicine Tangzhi'an for treating peripheral nerve lesion of diabetes
1 ... 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 ... 1259